Pular para o conteúdo
Síndrome de deleção 22q11.2
ORPHA:567CID-10 · D82.1CID-11 · LD44.N0DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
heartInício todas idadesHerança AD
Também conhecida comoSíndrome DiGeorgeSíndrome ShprintzenCATCH 22Síndrome velocardiofacialCATCH 22VCFSCATCH-22SD
Sinônimos clínicos: Síndrome DiGeorge · Síndrome Shprintzen · CATCH 22 · +1

A síndrome de deleção 22q11.2 (SD) é uma anomalia cromossômica que causa um distúrbio de malformação congênita cujas características comuns incluem defeitos cardíacos, anomalias palatais, dismorfismo facial, atraso no desenvolvimento e deficiência imunológica.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A síndrome da deleção 22q11.2 (que também é conhecida por vários outros nomes, listados abaixo) é um distúrbio causado pela deleção de um pequeno fragmento do cromossomo 22. A deleção ocorre próximo ao meio do cromossomo em uma localização designada q11.2.

A síndrome da deleção 22q11.2 tem muitos sinais e sintomas possíveis que podem afetar quase qualquer parte do corpo. As características desta síndrome variam amplamente, mesmo entre membros afetados da mesma família. Pessoas com a síndrome da deleção 22q11.2 costumam ter anomalias cardíacas que frequentemente estão presentes desde o nascimento, infecções recorrentes causadas por problemas no sistema imunológico e características faciais distintas. Nos indivíduos afetados, os músculos que formam o teto da boca (palato) podem não se fechar completamente, embora o tecido que os cobre o faça, resultando em uma condição chamada palato fissurado submucoso. O palato anormal costuma ser altamente arqueado e pode haver uma divisão na lâmina macia de tecido que pendura da parte posterior da boca (úvula bifida). O palato fissurado submucoso também pode interferir na fala normal ao fazer com que o ar escape pelo nariz durante a fala, levando a uma fala com som nasal. Indivíduos afetados podem ainda apresentar problemas respiratórios, anomalias renais, baixos níveis de cálcio no sangue (o que pode resultar em convulsões), diminuição das plaquetas sanguíneas (trombocitopenia), dificuldades alimentares significativas, problemas gastrointestinais e perda auditiva. Diferenças esqueléticas são possíveis, incluindo baixa estatura leve e, com menos frequência, anomalias nos ossos da coluna vertebral.

Muitas crianças com a síndrome da deleção 22q11.2 apresentam atrasos no desenvolvimento, incluindo crescimento retardado e desenvolvimento da fala atrasado, e algumas têm deficiência intelectual leve ou dificuldades de aprendizagem. Indivíduos mais velhos afetados têm dificuldade para ler, realizar tarefas que envolvem matemática e resolver problemas. Crianças com esta condição costumam precisar de ajuda para mudar e adaptar seus comportamentos ao responder a situações. Além disso, crianças afetadas têm maior probabilidade, em comparação com crianças sem a síndrome da deleção 22q11.2, de apresentar transtorno de déficit de atenção/hiperatividade (TDAH) e condições de desenvolvimento como transtorno do espectro autista, que afetam a comunicação e a interação social.

Como os sinais e sintomas da síndrome da deleção 22q11.2 são tão variados, diferentes agrupamentos de características foram, no passado, descritos como condições separadas. Os médicos nomearam essas condições como síndrome de DiGeorge, síndrome velocardiofacial (também chamada de síndrome de Shprintzen) e síndrome do rosto com anomalia conotruncal. Além disso, algumas crianças com a deleção 22q11.2 foram diagnosticadas com a forma autossômica dominante da síndrome de Opitz G/BBB e a síndrome cardiofacial de Cayler. Quando a base genética desses distúrbios foi identificada, os médicos determinaram que todas elas faziam parte de uma única síndrome com muitos sinais e sintomas possíveis. Para evitar confusão, esta condição costuma ser chamada de síndrome da deleção 22q11.2, uma descrição baseada em sua causa genética subjacente.

Fonte: MedlinePlus Genetics (NLM/NIH), traduzido
📋
Informacoes curadas por IA — podem conter imprecisoes

A síndrome de deleção 22q11.2 (SD) é uma anomalia cromossômica que causa um distúrbio de malformação congênita cujas características comuns incluem defeitos cardíacos, anomalias palatais, dismorfismo facial, atraso no desenvolvimento e deficiência imunológica.

Pesquisas ativas
10 ensaios
46 total registrados no ClinicalTrials.gov
Publicações científicas
1.837 artigos
Último publicado: 2026 Mar 10
Medicamentos
1 com registro
SIMULECT

Tem tratamento?

✓ 1 medicamento específico desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
SIMULECT
Mais 7 moléculas em estudo para esta doença.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
All ages
🏥
SUS: Cobertura mínimaScore: 0%
CID-10: D82.1
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
26 sintomas
🦴
Ossos e articulações
25 sintomas
❤️
Coração
16 sintomas
🧠
Neurológico
16 sintomas
🫃
Digestivo
15 sintomas
📏
Crescimento
12 sintomas

+ 76 sintomas em outras categorias

Características mais comuns

90%prev.
Morfologia anormal da valva pulmonar
Muito frequente (99-80%)
90%prev.
Hipotonia
Muito frequente (99-80%)
90%prev.
Fala hipernasal
Muito frequente (99-80%)
90%prev.
Platibasia
Muito frequente (99-80%)
90%prev.
Tetralogia de Fallot
Muito frequente (99-80%)
90%prev.
Morfologia anormal do sistema cardiovascular
Muito frequente (99-80%)
234sintomas
Muito frequente (24)
Frequente (35)
Ocasional (72)
Sem dados (103)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 234 características clínicas mais associadas, ordenadas por frequência.

Morfologia anormal da valva pulmonarAbnormal pulmonary valve morphology
Muito frequente (99-80%)90%
HipotoniaHypotonia
Muito frequente (99-80%)90%
Fala hipernasalHypernasal speech
Muito frequente (99-80%)90%
PlatibasiaPlatybasia
Muito frequente (99-80%)90%
Tetralogia de FallotTetralogy of Fallot
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.837PubMed
Últimos 10 anos200publicações
Pico202448 papers
Linha do tempo
2026Hoje · 2026🧪 1967Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

12 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.

ARVCFSplicing regulator ARVCFRole in the phenotype ofTolerante
OUTRAS DOENÇAS (1)
22q11.2 deletion syndrome
HGNC:728UniProt:O00192
BCRBreakpoint cluster region proteinCandidate gene tested inRestrito
VIAS BIOLÓGICAS (7)
RAC3 GTPase cycleRHOB GTPase cycleRAC1 GTPase cycleRAC2 GTPase cycleCDC42 GTPase cycle
MECANISMO DE DOENÇA

Leukemia, chronic myeloid

A clonal myeloproliferative disorder of a pluripotent stem cell with a specific cytogenetic abnormality, the Philadelphia chromosome (Ph), involving myeloid, erythroid, megakaryocytic, B-lymphoid, and sometimes T-lymphoid cells, but not marrow fibroblasts.

OUTRAS DOENÇAS (4)
chronic myelogenous leukemia, BCR-ABL1 positivechromosome 22q11.2 deletion syndrome, distalB-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)precursor T-cell acute lymphoblastic leukemia
HGNC:1014UniProt:P11274
MAPK1Mitogen-activated protein kinase 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
Negative regulation of MAPK pathwayRAF-independent MAPK1/3 activationSignaling by LTK in cancerAdvanced glycosylation endproduct receptor signalingSignaling by BRAF and RAF1 fusions
MECANISMO DE DOENÇA

Noonan syndrome 13

A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. NS13 inheritance is autosomal dominant. There is considerable variability in severity.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
62.5 TPM
Cérebro - Hemisfério cerebelar
57.4 TPM
Brain Frontal Cortex BA9
49.8 TPM
Brain Caudate basal ganglia
44.7 TPM
Nervo tibial
42.5 TPM
OUTRAS DOENÇAS (2)
Noonan syndrome 13chromosome 22q11.2 deletion syndrome, distal
HGNC:6871UniProt:P28482
CRKLCrk-like proteinCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (6)
Frs2-mediated activationMET activates RAP1 and RAC1MET receptor recyclingDownstream signal transductionRegulation of signaling by CBL
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
71.8 TPM
Linfócitos
70.4 TPM
Cerebelo
69.1 TPM
Útero
50.7 TPM
Fibroblastos
47.5 TPM
OUTRAS DOENÇAS (1)
chromosome 22q11.2 deletion syndrome, distal
HGNC:2363UniProt:P46109
COMTCatechol O-methyltransferaseRole in the phenotype ofTolerante
VIAS BIOLÓGICAS (1)
Methylation
MECANISMO DE DOENÇA

Schizophrenia

A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder.

OUTRAS DOENÇAS (1)
22q11.2 deletion syndrome
HGNC:2228UniProt:P21964
UFD1Ubiquitin recognition factor in ER-associated degradation protein 1Role in the phenotype ofAltamente restrito
VIAS BIOLÓGICAS (4)
NeddylationKEAP1-NFE2L2 pathwayDengue Virus Genome Translation and ReplicationRibosome Quality Control (RQC) complex extracts and degrades nascent peptide
OUTRAS DOENÇAS (1)
22q11.2 deletion syndrome
HGNC:12520UniProt:Q92890
SEC24CProtein transport protein Sec24CModifying germline mutation inAltamente restrito
VIAS BIOLÓGICAS (6)
Antigen Presentation: Folding, assembly and peptide loading of class I MHCSARS-CoV-2 activates/modulates innate and adaptive immune responsesMHC class II antigen presentationRegulation of cholesterol biosynthesis by SREBP (SREBF)COPII-mediated vesicle transport
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
106.8 TPM
Cervix Endocervix
65.1 TPM
Fibroblastos
64.2 TPM
Esôfago - Mucosa
63.2 TPM
Útero
63.1 TPM
OUTRAS DOENÇAS (1)
22q11.2 deletion syndrome
HGNC:10705UniProt:P53992
GP1BBPlatelet glycoprotein Ib beta chainRole in the phenotype ofTolerante
VIAS BIOLÓGICAS (7)
Intrinsic Pathway of Fibrin Clot FormationDefective F9 activationGP1b-IX-V activation signallingPlatelet Aggregation (Plug Formation)Platelet Adhesion to exposed collagen
MECANISMO DE DOENÇA

Bernard-Soulier syndrome

An autosomal recessive coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, thrombocytopenia, and impaired prothrombin consumption.

OUTRAS DOENÇAS (4)
Bernard-Soulier syndromeautosomal dominant macrothrombocytopenia22q11.2 deletion syndromefetal and neonatal alloimmune thrombocytopenia
HGNC:4440UniProt:P13224
JMJD1CJumonji domain-containing protein 1CModifying germline mutation inAltamente restrito
VIAS BIOLÓGICAS (1)
Factors involved in megakaryocyte development and platelet production
EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
55.1 TPM
Cérebro - Hemisfério cerebelar
48.8 TPM
Cervix Endocervix
30.5 TPM
Linfócitos
30.3 TPM
Útero
29.5 TPM
OUTRAS DOENÇAS (2)
22q11.2 deletion syndromepineal region germinoma
HGNC:12313UniProt:Q15652
RREB1Ras-responsive element-binding protein 1Modifying germline mutation inAltamente restrito
EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
36.9 TPM
Vagina
27.9 TPM
Skin Sun Exposed Lower leg
27.6 TPM
Tireoide
27.4 TPM
Skin Not Sun Exposed Suprapubic
27.2 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
22q11.2 deletion syndrome
HGNC:10449UniProt:Q92766
HIRAProtein HIRARole in the phenotype ofAltamente restrito
VIAS BIOLÓGICAS (2)
Formation of Senescence-Associated Heterochromatin Foci (SAHF)Replacement of protamines by nucleosomes in the male pronucleus
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
145.2 TPM
Cérebro - Hemisfério cerebelar
43.7 TPM
Cerebelo
43.1 TPM
Pituitária
30.9 TPM
Nervo tibial
30.4 TPM
OUTRAS DOENÇAS (1)
22q11.2 deletion syndrome
HGNC:4916UniProt:P54198
TBX1T-box transcription factor TBX1Role in the phenotype ofRestrito
VIAS BIOLÓGICAS (1)
Cardiogenesis
VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
34.8 TPM
Músculo esquelético
27.5 TPM
Tireoide
22.5 TPM
Fallopian Tube
19.1 TPM
Cervix Ectocervix
15.9 TPM
OUTRAS DOENÇAS (9)
tetralogy of fallotvelocardiofacial syndromeDiGeorge syndromeconotruncal heart malformations
HGNC:11592UniProt:O43435

Medicamentos e terapias

TERIPARATIDE ACETATEPhase 3

Mecanismo: Parathyroid hormone receptor agonist

MYCOPHENOLATE MOFETILPhase 1

Mecanismo: Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor

CYCLOSPORINEPhase 1

Mecanismo: Cyclophilin A modulator

TACROLIMUS ANHYDROUSPhase 1

Mecanismo: FK506-binding protein 1A inhibitor

METHYLPREDNISOLONEPhase 1

Mecanismo: Glucocorticoid receptor agonist

BASILIXIMABPhase 1

Mecanismo: Interleukin-2 receptor inhibitor

DACLIZUMABPhase 1

Mecanismo: Interleukin-2 receptor inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

606 variantes patogênicas registradas no ClinVar.

🧬 ARVCF: GRCh38/hg38 22q11.21(chr22:18919477-21459713)x3 ()
🧬 ARVCF: GRCh38/hg38 22q11.21(chr22:18929330-20686544)x1 ()
🧬 ARVCF: GRCh38/hg38 22q11.21(chr22:19017218-21105423)x1 ()
🧬 ARVCF: GRCh38/hg38 22q11.21(chr22:18161474-21110475)x3 ()
🧬 ARVCF: GRCh38/hg38 22q11.21(chr22:18929330-21110475)x1 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 14 variantes classificadas pelo ClinVar.

12
2
Patogênica (85.7%)
VUS (14.3%)
VARIANTES MAIS SIGNIFICATIVAS
BCR: GRCh37/hg19 22q11.22-11.23(chr22:22989174-23657759)x1 [Likely pathogenic]
BCR: NC_000022.10:g.(?_21797384)_(23630313_?)del [Pathogenic]
AIFM3: GRCh37/hg19 22q11.21(chr22:18893838-21416074)x3 [Pathogenic]
AIFM3: GRCh37/hg19 22q11.21(chr22:20609932-21576553)x1 [Pathogenic]
ARVCF: GRCh37/hg19 22q11.21(chr22:18893838-20508931)x3 [Pathogenic]

Vias biológicas (Reactome)

71 vias biológicas associadas aos genes desta condição.

Signaling by cytosolic FGFR1 fusion mutants Signaling by FGFR1 in disease RHOA GTPase cycle RHOB GTPase cycle RHOC GTPase cycle CDC42 GTPase cycle RAC1 GTPase cycle RAC2 GTPase cycle RAC3 GTPase cycle phospho-PLA2 pathway RAF-independent MAPK1/3 activation MAPK1 (ERK2) activation Signaling by NODAL Spry regulation of FGF signaling Signaling by Activin Golgi Cisternae Pericentriolar Stack Reorganization Frs2-mediated activation ERK/MAPK targets ERKs are inactivated Regulation of actin dynamics for phagocytic cup formation Downregulation of SMAD2/3:SMAD4 transcriptional activity SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription Oxidative Stress Induced Senescence Senescence-Associated Secretory Phenotype (SASP) Oncogene Induced Senescence FCERI mediated MAPK activation Regulation of HSF1-mediated heat shock response NCAM signaling for neurite out-growth Recycling pathway of L1 RSK activation Signal transduction by L1 Activation of the AP-1 family of transcription factors Thrombin signalling through proteinase activated receptors (PARs) Negative regulation of FGFR1 signaling Negative regulation of FGFR2 signaling Negative regulation of FGFR3 signaling Negative regulation of FGFR4 signaling RHO GTPases Activate WASPs and WAVEs RHO GTPases Activate NADPH Oxidases Downstream signal transduction MET activates RAP1 and RAC1 MET receptor recycling Erythropoietin activates RAS Regulation of signaling by CBL Methylation Enzymatic degradation of dopamine by COMT Enzymatic degradation of Dopamine by monoamine oxidase Potential therapeutics for SARS Translesion Synthesis by POLH Ub-specific processing proteases Neddylation KEAP1-NFE2L2 pathway Dengue Virus Genome Translation and Replication Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide Regulation of cholesterol biosynthesis by SREBP (SREBF) COPII-mediated vesicle transport MHC class II antigen presentation Cargo concentration in the ER SARS-CoV-2 activates/modulates innate and adaptive immune responses Antigen Presentation: Folding, assembly and peptide loading of class I MHC Intrinsic Pathway of Fibrin Clot Formation GP1b-IX-V activation signalling Platelet Adhesion to exposed collagen Platelet Aggregation (Plug Formation) Defective F9 activation Enhanced binding of GP1BA variant to VWF multimer:collagen Defective binding of VWF variant to GPIb:IX:V Factors involved in megakaryocyte development and platelet production Formation of Senescence-Associated Heterochromatin Foci (SAHF) Replacement of protamines by nucleosomes in the male pronucleus Cardiogenesis

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado1
3Fase 32
2Fase 29
1Fase 110
·Pré-clínico31
Medicamentos catalogadosEnsaios clínicos· 7 medicamentos · 46 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de deleção 22q11.2

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 6 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

9 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

46 ensaios clínicos encontrados, 10 ativos.

Distribuição por fase
NCT01821781 · Immune Disorder HSCT ProtocolAtivo
PHASE2🇺🇸 Estados Unidos
NCT05290493 · NB-001 in Children and Adolescents With 22q11 Deletion Syndr…Concluído
PHASE2🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT04141540 · Molecular Variants Associated With Schizophrenia: Differenti…Concluído
NA🇫🇷 França
NCT05149898 · Open-Label Study of ZYN002 Administered as a Transdermal Gel…Concluído
PHASE2🇦🇺 Austrália · 🇺🇸 Estados Unidos
NCT02895906 · Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Ye…Concluído
PHASE1🇺🇸 Estados Unidos
NCT04647500 · Effects of Methylphenidate on Brain and Cognition in 22q11 D…Concluído
NA🇨🇭 Suíça
NCT02787486 · Expanded Noninvasive Genomic Medical Assessment: The Enigma …Concluído
🇺🇸 Estados Unidos
NCT02541058 · Non-Invasive Chromosomal Evaluation of 22q11.2Concluído
🇧🇪 Bélgica
NCT02381457 · SNP-based Microdeletion and Aneuploidy RegisTry (SMART)Concluído
🇦🇺 Austrália · 🇮🇪 Irlanda · 🇪🇸 Espanha +3
NCT02460328 · Resolution of Primary Immune Defect in 22q11.2 Deletion Synd…Concluído
Thailand
NCT01647295 · Social Interactions: Ocular Explorations and Pupillometry in…Concluído
🇫🇷 França
NCT01220531 · Thymus Transplantation Safety-EfficacyConcluído
NA🇺🇸 Estados Unidos
NCT01781923 · Cognitive Remediation in 22q11DSConcluído
NA🇺🇸 Estados Unidos
NCT00917189 · Computerized Cognitive Skills Training for Adolescents With …Concluído
NA🇺🇸 Estados Unidos
NCT00837603 · Physical Training in Transposition of the Great ArteriesConcluído
NA🇩🇪 Alemanha
NCT00916955 · Genetic Modifiers for 22q11.2 SyndromeConcluído
🇺🇸 Estados Unidos
NCT00784173 · Middle and Inner Ear Malformation in Children With Velocardi…Concluído
NCT00579527 · Phase I/II Thymus Transplantation With Immunosuppression #95…Concluído
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT00105274 · Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome StudyConcluído
🇺🇸 Estados Unidos
NCT00566488 · Parathyroid and Thymus Transplantation in DiGeorge #931Concluído
PHASE1🇺🇸 Estados Unidos
NCT00576836 · Thymus Transplantation Dose in DiGeorge #932Concluído
PHASE2🇺🇸 Estados Unidos
NCT00579709 · Thymus Transplantation With ImmunosuppressionConcluído
PHASE1🇺🇸 Estados Unidos
NCT00004351 · Study of Phenotype and Genotype Correlations in Patients Wit…Concluído
🇺🇸 Estados Unidos
NCT00004361 · Study of the Relationship Between Calcium Levels and Intact …Concluído
NCT00576407 · Thymus Transplantation in DiGeorge Syndrome #668Concluído
PHASE2🇺🇸 Estados Unidos
NCT04470739 · Is Thymus Size of Infants Who Born to COVID-19 Positive Moth…UNKNOWN
NATurkey (Türkiye)
NCT02430584 · Whole Blood Specimen Collection From Pregnant SubjectsUNKNOWN
🇺🇸 Estados Unidos
NCT00161109 · Genetics and Psychopathology in the 22q11 Deletion SyndromeUNKNOWN
🇳🇱 Países Baixos · 🇺🇸 Estados Unidos
NCT00005102 · Immunologic Evaluation in Patients With DiGeorge Syndrome or…UNKNOWN
🇺🇸 Estados Unidos
NCT04373226 · Arithmetic Abilities in Children With 22q11.2DSEncerrado
NA🇫🇷 França
NCT03284060 · Social Cognition Training and Cognitive RemediationEncerrado
NA🇫🇷 França
NCT04639960 · Neuroprotective Effects of Risperdal on Brain and Cognition …Encerrado
NA🇨🇭 Suíça
NCT01127503 · Metyrosine (Demser®) for the Treatment of Psychotic Disorder…Encerrado
PHASE2🇺🇸 Estados Unidos
NCT00849888 · Serum-Free Thymus Transplantation in DiGeorge AnomalyEncerrado
PHASE1
NCT00395538 · Effects of PTH Replacement on Bone in HypoparathyroidismEncerrado
PHASE3🇺🇸 Estados Unidos
NCT00278005 · Infection in DiGeorge Following CHD SurgeryEncerrado
🇺🇸 Estados Unidos
NCT00267397 · Prevalence and Clinical Spectrum of the 22q11 DeletionEncerrado
🇺🇸 Estados Unidos
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
1.292 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.292

#1

Interhemispheric CA1 projections to the subiculum support spatial cognition and are affected in a mouse model of the 22q11.2 deletion syndrome.

Cell reports2026 Mar 20

Mapping hippocampal connectivity is essential to understand the neural mechanisms of learning and memory, yet interhemispheric connections between hippocampal formations remain poorly defined. In rodents, two main commissural pathways are known: dentate gyrus hilar mossy cells project to the inner molecular layer of the contralateral dentate gyrus, and CA2/CA3 pyramidal neurons send collaterals to contralateral CA3, CA2, and CA1 regions. By contrast, commissural outputs from CA1 remain largely unexplored. Here, we show that dorsal CA1 (dCA1) pyramidal neurons located in the right hemisphere project to contralateral dorsal subiculum (dSUB) in addition to contralateral dCA1. We then assess the function of the projection from the right dCA1 to the left dSUB and find that this interhemispheric pathway supports spatial memory and spatial working memory, two cognitive functions altered in the Df16(A)+/- mouse model of 22q11.2 deletion syndrome (22q11.2DS) associated with schizophrenia. Notably, the right-to-left dCA1 interhemispheric projections are disrupted in Df16(A)+/- mice, suggesting that dysregulation of this circuit may contribute to 22q11.2DS-related cognitive deficits.

#2

Charting Brain Structure in 22q11.2 Deletion Syndrome with Clinical Neuroimaging.

medRxiv : the preprint server for health sciences2026 Jan 23

22q11.2 deletion syndrome (22q11DS) is a common microdeletion associated with widespread brain alterations and elevated risk for schizophrenia and other neuropsychiatric conditions. Prospective research studies often exclude individuals with severe cognitive impairment, medical comorbidities, or inability to tolerate research MRI without sedation, features common in 22q11DS. This limits both the generalizability of neuroimaging findings and our understanding of the full phenotypic spectrum. Moreover, while standard brain growth charts quantify deviation from typical development, they cannot identify patients who are disproportionately affected relative to their genetic peers, limiting clinical utility for risk stratification. Leveraging clinical MRI data offers a scalable approach to address these gaps. We analyzed 92 patients with 22q11DS (age 0.5-21 years, 49% female) and 252 matched clinical controls. Using normative modeling derived from 1,995 reference clinical scans, we quantified individual-level brain deviations from population norms. We validated clinical findings against the independent ENIGMA-22q research consortium, characterized rates of extreme structural deviations to assess within-syndrome heterogeneity, correlated spatial patterns of brain alterations with gene expression from the Allen Human Brain Atlas, and generated syndrome-specific growth charts to test whether deviations from syndrome-specific norms predicted cognitive and language outcomes. Patients with 22q11DS showed widespread reductions in brain volumes (max Cohen's d=-1.31) and cortical surface area (d=-0.71) with increased cortical thickness (d=0.39). These findings were highly convergent with the ENIGMA-22q research cohort (r=0.61-0.87). Forty percent of patients showed at least one global brain measure below the 2.5th percentile. Spatial patterns of cortical volume and surface area correlated with the expression of genes within the 22q11.2 locus. Critically, syndrome-specific growth charts revealed that smaller cerebellar volume relative to 22q11DS peers predicted lower language scores across two independent assessment methods (p<0.03), demonstrating potential prognostic utility. This study provides a critical proof of principle for using heterogeneous clinical imaging to robustly characterize brain structure in rare genetic disorders. Syndrome-specific growth charts provide a novel framework to quantify within-syndrome variability and demonstrate potential prognostic value by linking individual brain structure to cognitive outcomes.

#3

Challenging Case: Complex Developmental Care and Management in a Child With a Chromosomal Deletion.

Journal of developmental and behavioral pediatrics : JDBP2026 Jan 02
#4

DiGeorge for the Otolaryngologist: A State-of-the-Art Review.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2026 Mar 09

To provide a state-of-the-art, otolaryngology-focused review of 22q11.2 deletion syndrome (22q11.2DS), emphasizing recent developments in the understanding of airway, hearing, velopharyngeal, sleep, and perioperative manifestations that directly influence contemporary ENT practice. PubMed, Scopus, and Cochrane Library were searched for English-language publications from January 2018 to September 2025. Additional data were identified through reference lists of key guidelines and landmark cohort studies. A narrative review approach was used to synthesize recent literature addressing the epidemiology, anatomy, diagnostic advances, and management of otologic, palatal, airway, sleep, swallowing, vascular, immune, and perioperative features of 22q11.2DS. Priority was given to studies published within the past 5 years, multicenter analyses, updated clinical practice guidelines, and investigations describing evolving surgical and diagnostic paradigms. Articles focusing solely on cardiac, endocrine, or psychiatric aspects were excluded unless directly relevant to otolaryngologic care. 22q11.2DS presents a uniquely high burden of ENT disease across the lifespan, including chronic otitis media, elevated cholesteatoma risk, persistent velopharyngeal dysfunction, multilevel airway anomalies, sleep-disordered breathing, dysphagia, and perioperative vulnerability due to vascular, immunologic, and hematologic anomalies. Emerging imaging techniques, updated pediatric and adult guidelines, and expanded genotype-phenotype data have reshaped diagnostic and surgical strategies. Otolaryngologists play a central role in lifelong care of individuals with 22q11.2DS. Structured surveillance, genotype-informed imaging, proactive sleep and airway assessment, and multidisciplinary perioperative planning are essential for improving outcomes. Standardized pathways and longitudinal, ENT-specific research are urgently needed to guide evidence-based management.

#5

Different Diagnoses, Common Ancestry: 22q11.2 Deletion Syndrome and Wiskott-Aldrich Syndrome in the Same Family.

Molecular syndromology2026 Jan 19

Newborn screening program enable pre-symptomatic detection patients with severe forms of T and B cell immunodeficiency. Despite the high prevalence of 22q11.2 deletion syndrome, only 1 in 10 patients develop lymphopenia that can be detected by newborn screening program. This report presents a unique familial case of 22q11.2 deletion syndrome and Wiskott-Aldrich syndrome, highlighting the importance genetic counseling and a detailed analysis of the family history. The article presents a case of the two rare genetic diseases in patients from the same family: 22q11.2 deletion syndrome in one and Wiskott-Aldrich syndrome in the other. Both diseases belong to the group of combined immunodeficiencies with syndromic features and are potentially life-threatening conditions requiring follow-up by a wide range of specialists: immunologists, geneticists, cardiologists, endocrinologists, and medical psychologists. Our work aimed to describe the clinical manifestations, genetic characteristics, and diagnosis of these disorders. It is worth emphasizing that the timely diagnosis of not only 22q11.2 deletion syndrome but also other primary immunodeficiencies in the Russian Federation became possible due to the introduction of extended neonatal screening into widespread practice. For such patients, comprehensive early interventional treatment and follow-up by a wide range of specialists is important to improve prognosis and quality of life.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.275 artigos no totalmostrando 199

2026

EEG power spectral and microstate analyses in the 22q11.2 deletion syndrome: from genetic risk to schizophrenia.

Journal of neural transmission (Vienna, Austria : 1996)
2026

Interhemispheric CA1 projections to the subiculum support spatial cognition and are affected in a mouse model of the 22q11.2 deletion syndrome.

Cell reports
2026

DiGeorge for the Otolaryngologist: A State-of-the-Art Review.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
2026

Different Diagnoses, Common Ancestry: 22q11.2 Deletion Syndrome and Wiskott-Aldrich Syndrome in the Same Family.

Molecular syndromology
2026

Genetic Mapping of the 22q11.2 Deletion Syndrome (DiGeorge Syndrome) Microdeletion Types Revealed Novel Candidate Breakpoints.

Genes
2026

Adaptive and Behavioral Phenotype in Pediatric 22q11.2 Deletion Syndrome: Characterizing a High-Risk Neurogenetic Copy Number Variant.

Genes
2026

The 22q11.2 deletion syndrome: Genetic mechanisms, clinical manifestations, and therapeutic strategies.

Clinica chimica acta; international journal of clinical chemistry
2026

Follicular Helper T Cells and B Cell Maturation in Patients with 22q11.2 Deletion Syndrome and Recurrent Infections.

Journal of clinical immunology
2026

22q11.2 Deletion Syndrome in Offspring Conceived via Assisted Reproductive Technology Versus Spontaneously.

Genes
2025

Navigating Services in the UK: The Lived Experiences of Families Affected by 22q11.2 Deletion Syndrome.

Behavioral sciences (Basel, Switzerland)
2025

Quantitative susceptibility mapping of deep brain nuclei in 22q11.2 deletion syndrome.

Frontiers in psychiatry
2025

Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndrome.

Research square
2026

Challenging Case: Complex Developmental Care and Management in a Child With a Chromosomal Deletion.

Journal of developmental and behavioral pediatrics : JDBP
2025

Evaluating the effectiveness of routine noninvasive prenatal screening for CNVs in 22q11.2 region in a cohort of 38,495 pregnancies.

Scientific reports
2025

Aripiprazole for treatment of attenuated psychosis syndrome in an adolescent with 22q11.21 deletion syndrome: A case report.

Medicine
2025

From DGCR8 expression analysis to diseased pathways in 22q11.2 deletion syndrome.

Frontiers in immunology
2025

A Rare Case of Coexisting 22q11.2 Deletion Syndrome and Cornelia De Lange Syndrome: A Case Report and Review of the Literature.

Cureus
2026

Charting Brain Structure in 22q11.2 Deletion Syndrome with Clinical Neuroimaging.

medRxiv : the preprint server for health sciences
2025

Urinary metabolomic profiling in 22q11.2 deletion syndrome reveals microbial and mitochondrial signatures related to autism and psychosis risk.

PCN reports : psychiatry and clinical neurosciences
2025

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review.

Movement disorders clinical practice
2025

Developmental Selective GSK3α Inhibition Rescues Working Memory Deficits in a Mouse Model of Schizophrenia Predisposition.

Complex psychiatry
2026

Otolaryngologic disease in 22q11.2 deletion syndrome: spectrum, co-occurrence, and outcomes in a contemporary pediatric cohort.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2025

Maternal Genotype and Dietary Vitamin A Modify Aortic Arch Phenotypes in a Mouse Model of 22q11DS.

International journal of molecular sciences
2025

Single cell RNA-seq analysis of hematopoietic cell types in 22q11.2 deletion syndrome reveals significant changes to non-T cells.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2025

Mexican Patients With Suspected 22q11.2 Deletion Syndrome: Clinical Characterization and Molecular Findings by Fluorescence In Situ Hybridization and Multiplex Ligation-Dependent Probe Amplification.

Molecular genetics &amp; genomic medicine
2025

Tracheal Compression on Chest X-ray Leading to the Diagnosis of Right Aortic Arch in 22q11.2 Deletion Syndrome.

Cureus
2025

Cognitive-Developmental Mechanisms in Hallucinations.

Schizophrenia bulletin
2026

Natural history study of scoliosis in patients with 22q11.2 deletion syndrome, starting before disease onset.

Spine deformity
2025

The acoustic startle response in 22q11 deletion syndrome: from animal models to humans.

Frontiers in neuroscience
2025

Successful use of clozapine in a patient with schizophrenia comorbid with 22q11.2 deletion syndrome and multiple periventricular nodular heterotopia: A case report.

PCN reports : psychiatry and clinical neurosciences
2025

Evaluating the relationship between caregiver depression, social support, and children's internalizing and externalizing symptoms in families affected by 22q11.2 deletion syndrome.

Orphanet journal of rare diseases
2025

Investigating the relationship between sleep disturbances and psychopathology In children and adolescents with microdeletion of 22q11 chromosome: an exploratory study.

Frontiers in psychiatry
2025

Parental Education Predicts Longitudinal IQ Trajectories in 22q11.2 Deletion Syndrome: A Three-Cohort European Study.

Journal of intellectual disability research : JIDR
2025

Autoantibodies in patients with 22q11.2 deletion syndrome and psychosis.

The Journal of allergy and clinical immunology
2025

Oxytocin seals the blood-brain barrier, improving 22q11.2 deletion syndrome trajectories.

Brain : a journal of neurology
2025

Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome.

Scientific reports
2025

Correlation between 22q11.2 deletion syndrome phenotype and deletion location: a meta-analysis.

Archives of gynecology and obstetrics
2025

Dissecting the Phenotypic Spectrum and Complexity of Movement Disorders in 22q11.2 Deletion Syndrome.

European journal of neurology
2025

Age-Related Dysphagia Among Children with 22q11.2-Deletion Syndrome.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2025

Penetrance of Neurodevelopmental Copy Number Variants Is Associated With Variations in Cortical Morphology.

Biological psychiatry. Cognitive neuroscience and neuroimaging
2025

Streamlined Preoperative Evaluation of Velopharyngeal Dysfunction: A Single-Session Protocol for Speech MRI and Carotid MRA.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2025

Presence, Severity, and Functional Associations of Incomplete Hippocampal Inversion in 22q11.2 Deletion Syndrome.

Biological psychiatry. Cognitive neuroscience and neuroimaging
2025

Self-Esteem and Psychopathology Differentially Relate to Real-Life and Social Functioning in People With 22q11.2 Deletion Syndrome.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2025

Assessment of vascular tortuosity in 22q11.2 deletion syndrome using optical coherence tomography angiography.

Photodiagnosis and photodynamic therapy
2025

Healthcare Transition to Adulthood in Patients with 22q11.2 Deletion Syndrome: A Comprehensive Literature Review and Transition Framework.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2025

Prevalence of cholesteatoma in children with 22q11.2 deletion syndrome.

International journal of pediatric otorhinolaryngology
2025

Children With 22.Q.11.2 Deletion Syndrome: Sleep-Disordered Breathing and Management.

American journal of medical genetics. Part A
2025

Phonemic-Phonological Profile of People with 22q11.2 Deletion Syndrome: A Pilot Study.

Brain sciences
2025

Investigation of 22q11.2 Deletion Syndrome in the first Moroccan Pediatric Patients series.

La Tunisie medicale
2025

Review of the Pathophysiology and Clinical Manifestations of 22q11.2 Deletion and Duplication Syndromes.

Clinical reviews in allergy &amp; immunology
2025

Perception of psychosocial burden in mothers of children with rare pediatric neurological diseases.

Scientific reports
2024

Driving Innovation to Support Pupils with SEND Through Co-Production in Education and Research: Participatory Action Research with 22q11.2 Deletion Syndrome Families in England.

Behavioral sciences (Basel, Switzerland)
2025

Development of a TaqMan-based dosage analysis PCR assay for the molecular diagnosis of 22q11.2 deletion syndrome.

Genes &amp; genetic systems
2025

Sleep difficulties related to psychopathology and neurocognition in people with 22q11.2 deletion syndrome.

Psychiatry research
2025

Real-Life Functioning in 22q11.2 Deletion Syndrome in Relation to Neurocognitive Abilities and Psychotic Symptoms: A Comparison With Idiopathic Schizophrenia.

Journal of intellectual disability research : JIDR
2024

Investigating psychiatric morbidity, hopelessness and suicide risk in patients with 22q11.2 deletion syndrome: a case-control study.

International journal of psychiatry in clinical practice
2024

Muscle Weakness in an Adult With 22q11.2 Deletion Syndrome.

CNS neuroscience &amp; therapeutics
2024

Sensory Processing Challenges in Children with Neurodevelopmental Disorders and Genetic Conditions: An Observational Study.

NeuroSci
2025

Hearing Loss in Children with 22q11.2 Deletion Syndrome.

The Laryngoscope
2024

European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia.

The Journal of allergy and clinical immunology
2025

An Assessment of Adverse Events in Patients with 22q11.2 Deletion Syndrome Undergoing Palatoplasty: An Analysis of the NSQIP Pediatric Database.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2024

Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome.

Pediatric blood &amp; cancer
2024

The Co-Occurrence of 22q11.2 Deletion Syndrome and Epithelial Basement Membrane Dystrophy: A Case Report and Review of the Literature.

Life (Basel, Switzerland)
2024

Treatment-resistant schizophrenia with 22q11.2 deletion and additional genetic defects.

Neuropsychopharmacology reports
2025

Unique Functional Neuroimaging Signatures of Genetic Versus Clinical High Risk for Psychosis.

Biological psychiatry
2025

An uncommon neuroradiological finding of hippocampal malrotation in childhood onset schizophrenia and 22q11.2 Deletion Syndrome: a case report and a brief review of the literature.

European child &amp; adolescent psychiatry
2024

The 22q11.2 Deletion Syndrome from A Biopsychosocial Perspective: A Series of Cases with an ICF-Based Approach.

Children (Basel, Switzerland)
2024

Comparison of the Accuracy in Provisional Diagnosis of 22q11.2 Deletion and Williams Syndromes by Facial Photos in Thai Population Between De-Identified Facial Program and Clinicians.

The application of clinical genetics
2024

Comprehensive insights into health services accessibility and quality of life of families with individuals with 22q11.2 deletion syndrome in Brazil.

Orphanet journal of rare diseases
2024

Cancer in 22q11.2 deletion syndrome: A case report and literature review.

European journal of medical genetics
2024

Extent of magnitude representation deficit and relationship with arithmetic skills in children with 22q11.2DS.

Orphanet journal of rare diseases
2024

Aerodynamic Study of Velopharyngeal Insufficiency in 22q11.2 Deletion Syndrome.

Journal of personalized medicine
2024

Computer-vision analysis of craniofacial dysmorphology in 22q11.2 deletion syndrome and psychosis spectrum disorders.

Journal of neurodevelopmental disorders
2024

Human Genetics of Truncus Arteriosus.

Advances in experimental medicine and biology
2024

Next-generation sequencing profiling of miRNAs in individuals with 22q11.2 deletion syndrome revealed altered expression of miR-185-5p.

Human genomics
2024

Multicenter appraisal of comorbid TANGO2 deficiency disorder in patients with 22q11.2 deletion syndrome.

American journal of medical genetics. Part A
2024

Neuropsychological Profile of 25 Brazilian Patients with 22q11.2 Deletion Syndrome: Effects of Clinical and Socioeconomic Variables.

Genes
2024

Reduced amplitude and slowed latency of the acoustic startle response in adolescents and adults with 22q11.2 deletion syndrome.

Schizophrenia research
2024

22q11.2 Deletion Syndrome: Influence of Parental Origin on Clinical Heterogeneity.

Genes
2024

Genome Sequencing in an Individual Presenting with 22q11.2 Deletion Syndrome and Juvenile Idiopathic Arthritis.

Genes
2024

Neuroanatomical Correlates of Cognitive Dysfunction in 22q11.2 Deletion Syndrome.

Genes
2024

The impact of social-environmental factors on IQ in syndromic intellectual developmental disabilities.

Journal of clinical and translational science
2024

Bernard-Soulier syndrome caused by a novel GP1BB variant and 22q11.2 deletion.

International journal of hematology
2024

A regulatory variant impacting TBX1 expression contributes to basicranial morphology in Homo sapiens.

American journal of human genetics
2024

22q11.2 Deletion-Associated Blood-Brain Barrier Permeability Potentiates Systemic Capillary Leak Syndrome Neurologic Features.

Journal of clinical immunology
2024

Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors.

Genes
2024

Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity.

Psychiatry research
2024

Thalamic contributions to psychosis susceptibility: Evidence from co-activation patterns accounting for intra-seed spatial variability (μCAPs).

Human brain mapping
2024

Congenital cytomegalovirus infection in a preterm infant with 22q11.2 deletion syndrome and immunological abnormalities.

Nagoya journal of medical science
2024

Social skills in neurodevelopmental disorders: a study using role-plays to assess adolescents and young adults with 22q11.2 deletion syndrome and autism spectrum disorders.

Journal of neurodevelopmental disorders
2024

Lymphoblast transcriptome analysis in 22q11.2 deletion syndrome individuals with schizophrenia-spectrum disorder.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
2024

An Infant Diagnosed With 22q11.2 Deletion Syndrome Following Frequent Apneic Attacks.

Cureus
2024

Using transcranial alternating current stimulation to enhance working memory skills in youths with 22q11.2 deletion syndrome: A randomized double-blind sham-controlled study.

Psychiatry research
2024

Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome.

Metabolomics : Official journal of the Metabolomic Society
2024

Mental health, coping, and protective factors in mothers of children with 22q11.2 deletion syndrome.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2024

Variants in KMT2A in Three Individuals with Previous Suspicion of 22q11.2 Deletion Syndrome.

Genes
2024

The effectiveness and tolerability of pharmacotherapy for psychosis in 22q11.2 Deletion Syndrome: A systematic review.

The Australian and New Zealand journal of psychiatry
2024

Remote assessment of the Penn computerised neurocognitive battery in individuals with 22q11.2 deletion syndrome.

Journal of intellectual disability research : JIDR
2023

Neonatal manifestation of 22q11.2 deletion syndrome - four case reports and a mini-literature review.

Annals of agricultural and environmental medicine : AAEM
2024

Dgcr8 functions in the secondary heart field for outflow tract and right ventricle development in mammals.

Developmental biology
2023

22q11.2 Deletion Syndrome Diagnosed 47 Years After Surgery for Tetralogy of Fallot.

Cureus
2024

Hypoparathyroidism Associated with Benign Thyroid Nodules in DiGeorge-like Syndrome: A Rare Case Report and Literature Review.

Endocrine, metabolic &amp; immune disorders drug targets
2024

Surgical Management of Velopharyngeal Dysfunction.

Facial plastic surgery clinics of North America
2023

Hypocalcemia and Graves' disease associated with 22q11.2 deletion syndrome.

Pediatrics international : official journal of the Japan Pediatric Society
2023

Exploring pathway interactions to detect molecular mechanisms of disease: 22q11.2 deletion syndrome.

Orphanet journal of rare diseases
2023

Incidental finding at methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA): how to proceed?

Frontiers in genetics
2023

22q11.2 Deletion Syndrome in Taiwan: Clinical Presentation and Immune System Status of Patients.

International journal of medical sciences
2023

Omenn syndrome in a 10-month-old male with athymia and VACTERL association.

The journal of allergy and clinical immunology. Global
2023

Neurodevelopmental dimensional assessment of young children at high genomic risk of neuropsychiatric conditions.

JCPP advances
2024

Prenatal vs postnatal diagnosis of 22q11.2 deletion syndrome: cardiac and noncardiac outcomes through 1 year of age.

American journal of obstetrics and gynecology
2023

Distinct neuroanatomical and neuropsychological features of Down syndrome compared to related neurodevelopmental disorders: a systematic review.

Frontiers in neuroscience
2024

Polysomnographic findings in children with 22q deletion & duplication syndrome: relationship to genetic diagnosis, parent-reported symptoms, and calcium levels.

Sleep &amp; breathing = Schlaf &amp; Atmung
2023

DiGeorge syndrome critical region gene 2 (DGCR2), a schizophrenia risk gene, regulates dendritic spine development through cell adhesion.

Cell &amp; bioscience
2023

[Prenatally detected aortic arch anomalies and their consequences after birth].

Orvosi hetilap
2023

Clinical Course and Outcome of Prenatally Detected 22q11.2 Deletion Syndrome-A Retrospective Analysis.

Diagnostics (Basel, Switzerland)
2024

Hardiness as a Resilience Factor for Adaptation in Families of Children With 22q11.2 Deletion Syndrome: A Mixed Methods Study of Parents' Perspectives.

Journal of intellectual disabilities : JOID
2023

Behaviors related to autism spectrum disorder in children with developmental language disorder and children with 22q11.2 deletion syndrome.

Autism &amp; developmental language impairments
2023

Distinct Neurocognitive Profiles and Clinical Phenotypes Associated with Copy Number Variation at the 22q11.2 Locus.

medRxiv : the preprint server for health sciences
2023

Neurodevelopmental and other psychiatric disorders in 22q11.2 deletion syndrome from childhood to adult age: Prospective longitudinal study of 100 individuals.

American journal of medical genetics. Part C, Seminars in medical genetics
2023

Histological Analysis of a Mouse Model of the 22q11.2 Microdeletion Syndrome.

Biomolecules
2023

Development of a storytelling communication facilitation tool (SCFT) to facilitate discussion of complex genetic diagnoses between parents and their children: A pilot study using 22q11.2 deletion syndrome as a model condition.

PEC innovation
2023

Multivariate patterns of disrupted sleep longitudinally predict affective vulnerability to psychosis in 22q11.2 Deletion Syndrome.

Psychiatry research
2023

Executive functioning in preschoolers with 22q11.2 deletion syndrome and the impact of congenital heart defects.

Journal of neurodevelopmental disorders
2023

Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis.

Frontiers in psychiatry
2023

Congenital Heart Defects and 22q11.2 Deletion Syndrome: A 20-Year Update and New Insights to Aid Clinical Diagnosis.

Journal of pediatric genetics
2023

An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience.

Journal of clinical research in pediatric endocrinology
2023

Psychosis spectrum features, neurocognition and functioning in a longitudinal study of youth with 22q11.2 deletion syndrome.

Psychological medicine
2023

Language Profiles of School-Aged Children with 22q11.2 Copy Number Variants.

Genes
2022

Aberrant right subclavian artery: embryology, prenatal diagnosis and clinical significance.

Ultrasound (Leeds, England)
2023

Positive cfDNA screening results for 22q11.2 deletion syndrome-Clinical and laboratory considerations.

Frontiers in genetics
2023

A case study of the utilization of clozapine treatment for treatment-resistant schizophrenia associated with 22q11.2 deletion syndrome.

Neuropsychopharmacology reports
2023

Chromosome 22q11.2 Deletion (DiGeorge Syndrome): Immunologic Features, Diagnosis, and Management.

Current allergy and asthma reports
2023

Educational challenges for 22q11.2 deletion syndrome in Japan: Findings from a mixed methods survey.

Journal of applied research in intellectual disabilities : JARID
2023

22q11 Copy Number Variations in a Brazilian Cohort of Children with Congenital Heart Disorders.

Molecular syndromology
2023

Relationship between high trait anxiety in 22q11.2 deletion syndrome and the difficulties in medical, welfare, and educational services.

PCN reports : psychiatry and clinical neurosciences
2023

Phenotypic heterogeneity in 22q11.2 deletion syndrome: Copy Number Variants as genetic modifiers for congenital heart disease in a Brazilian cohort.

American journal of medical genetics. Part A
2023

Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome.

Genetics in medicine : official journal of the American College of Medical Genetics
2023

Sphincter Pharyngoplasty for Velopharyngeal Dysfunction: Impact of 22q11.2 Deletion Syndrome.

The Laryngoscope
2023

Gathering the Stakeholder's Perspective: Experiences and Opportunities in Rare Genetic Disease Research.

Genes
2023

Prenatal Screening and Diagnostic Considerations for 22q11.2 Microdeletions.

Genes
2022

Improved Outcomes in Patients with 22q11.2 Deletion Syndrome and Diagnosis of Interrupted Aortic Arch Prior to Birth Hospital Discharge, a Retrospective Study.

Genes
2024

Surgical Management of Submucous Cleft Palate by Radical Muscle Dissection Veloplasty: Speech Outcomes in Patients with 22q11.2 Deletion Syndrome.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2022

Clinical Risk Factors for Aortic Root Dilation in Patients with 22q11.2 Deletion Syndrome: A Longitudinal Single-Center Study.

Genes
2022

Tonsillectomy in Children with 22q11.2 Deletion Syndrome.

Genes
2022

The Potential Role of Dysregulated miRNAs in Adolescent Idiopathic Scoliosis and 22q11.2 Deletion Syndrome.

Journal of personalized medicine
2022

Structural Cerebellar Abnormalities and Parkinsonism in Patients with 22q11.2 Deletion Syndrome.

Brain sciences
2022

Reproductive Outcomes in Adults with 22q11.2 Deletion Syndrome.

Genes
2022

The 22q11.2 Low Copy Repeats.

Genes
2023

Cardiac function in adolescents and young adults with 22q11.2 deletion syndrome without congenital heart disease.

European journal of medical genetics
2022

A method of large DNA fragment enrichment for nanopore sequencing in region 22q11.2.

Frontiers in genetics
2023

Rare tandem repeat expansions associate with genes involved in synaptic and neuronal signaling functions in schizophrenia.

Molecular psychiatry
2022

The Unique Experience of a New Multidisciplinary Program for 22q Deletion and Duplication Syndromes in a Community Hospital in Florida: A Reaffirmation That Multidisciplinary Care Is Essential for Best Outcomes in These Patients.

Genes
2023

Immune status of the murine 22q11.2 deletion syndrome model.

European journal of immunology
2022

Airway anomalies in patients with 22q11.2 deletion syndrome: A scoping review.

International journal of pediatric otorhinolaryngology
2022

Parent-Reported Social-Communicative Skills of Children with 22q11.2 Copy Number Variants and Siblings.

Genes
2023

COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS.

The journal of allergy and clinical immunology. In practice
2023

Aortic Arch Laterality in Chromosome 22q11.2 Deletion Syndrome: Male-Female Difference.

Clinical pediatrics
2022

The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal 1H-MRS and 18F-Fallypride PET Study.

Genes
2022

A Novel Non-Allelic Homologous Recombination Event in a Parent with an 11;22 Reciprocal Translocation Leading to 22q11.2 Deletion Syndrome.

Genes
2022

Characterization of Autoimmune Thyroid Disease in a Cohort of 73 Paediatric Patients Affected by 22q11.2 Deletion Syndrome: Longitudinal Single-Centre Study.

Genes
2022

Bayesian inference of molecular kinetic parameters from astrocyte calcium imaging data.

MethodsX
2022

Laryngeal web with 22q11.2 deletion syndrome.

International journal of pediatrics &amp; adolescent medicine
2022

Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.

eLife
2022

Deletion Syndrome 22q11.2: A Systematic Review.

Children (Basel, Switzerland)
2022

Infectious Complications of DiGeorge Syndrome in the Setting of Malignancy.

Cureus
2022

Identification of 22q11.2 deletion in a patient with schizophrenia and clinically diagnosed Rubinstein-Taybi syndrome.

PCN reports : psychiatry and clinical neurosciences
2022

Sequential inhibitory plasticities in hippocampal area CA2 and social memory formation.

Neuron
2022

Post-traumatic stress in adults with 22q11.2 deletion syndrome.

BJPsych open
2023

Altered developmental trajectories of verbal learning skills in 22q11.2DS: associations with hippocampal development and psychosis.

Psychological medicine
2022

Congenital portosystemic venous shunt associated with 22q11.2 deletion syndrome: a case report.

BMC pediatrics
2022

22q11.2 Deletion Syndrome: Impact of Genetics in the Treatment of Conotruncal Heart Defects.

Children (Basel, Switzerland)
2022

Experimental and computational analyses of calcium dynamics in 22q11.2 deletion model astrocytes.

Neuroscience letters
2022

Craniofacial Phenotypes and Genetics of DiGeorge Syndrome.

Journal of developmental biology
2023

Assessment of the Velopharyngeal Mechanism at Rest and During Speech in Children With 22q11.2DS: A Cross-Sectional Study.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2022

Genome-wide tandem repeat expansions contribute to schizophrenia risk.

Molecular psychiatry
2022

Crossed pulmonary arteries: An underestimated cardiovascular variant with a strong association with genetic syndromes-A report of 74 cases with systematic review of the literature.

American journal of medical genetics. Part A
2022

Neural Networks for Classification and Image Generation of Aging in Genetic Syndromes.

Frontiers in genetics
2022

Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome.

Frontiers in endocrinology
2023

Talking with children and young people with 22q11DS about their mental health, behaviour, learning and communication.

Child: care, health and development
2023

Recognition of facial emotion expressions and perceptual processes in 22q11.2 deletion syndrome.

Early intervention in psychiatry
2022

Biallelic PAN2 variants in individuals with a syndromic neurodevelopmental disorder and multiple congenital anomalies.

European journal of human genetics : EJHG
2023

Increased Central Auditory Gain and Decreased Parvalbumin-Positive Cortical Interneuron Density in the Df1/+ Mouse Model of Schizophrenia Correlate With Hearing Impairment.

Biological psychiatry global open science
2022

Crossed pulmonary arteries and DiGeorge syndrome: case reports and literature review.

Cardiology in the young
2022

The COVID-19 pandemic's impact on worry and medical disruptions reported by individuals with chromosome 22q11.2 copy number variants and their caregivers.

Journal of intellectual disability research : JIDR
2022

An overview of the trajectory of Brazilian individuals with 22q11.2 deletion syndrome until diagnosis.

Orphanet journal of rare diseases
2022

Spectrum of Genetic T-Cell Disorders from 22q11.2DS to CHARGE.

Clinical reviews in allergy &amp; immunology
2022

Long-Term Follow-Up of Newborns with 22q11 Deletion Syndrome and Low TRECs.

Journal of clinical immunology
2022

Downregulation of miR-185 is a common pathogenic event in 22q11.2 deletion syndrome-related and idiopathic schizophrenia.

Metabolic brain disease
2022

A Regional Burden of Sequence-Level Variation in the 22q11.2 Region Influences Schizophrenia Risk and Educational Attainment.

Biological psychiatry
2022

Neurological manifestation of 22q11.2 deletion syndrome.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome.

American journal of obstetrics and gynecology
2023

Characterizing Daily-Life Social Interactions in Adolescents and Young Adults with Neurodevelopmental Disorders: A Comparison Between Individuals with Autism Spectrum Disorders and 22q11.2 Deletion Syndrome.

Journal of autism and developmental disorders
2023

A Comprehensive Analysis of Cerebellar Volumes in the 22q11.2 Deletion Syndrome.

Biological psychiatry. Cognitive neuroscience and neuroimaging
2021

Impact of Equine-Assisted Interventions on Heart Rate Variability in Two Participants with 22q11.2 Deletion Syndrome: A Pilot Study.

Children (Basel, Switzerland)
2022

Parents' perspectives, experiences, and need for support when communicating with their children about the psychiatric manifestations of 22q11.2 deletion syndrome (22q11DS).

Journal of community genetics
2022

Clinical Manifestations of 22q11.2 Deletion Syndrome.

Heart failure clinics
2022

Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study.

American journal of medical genetics. Part A
2021

22q11.2 Deletion Syndrome as a Human Model for Idiopathic Scoliosis.

Journal of clinical medicine
2022

Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia.

Schizophrenia bulletin open
Ver todos os 1.275 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de deleção 22q11.2.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Síndrome de deleção 22q11.2 e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma anomalia genética congênita caracterizada pela perda de material no cromossomo 22. Ela se manifesta tipicamente por defeitos no coração, alterações no palato, imunodeficiência e atraso no desenvolvimento.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 7 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. DiGeorge for the Otolaryngologist: A State-of-the-Art Review.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2026PMID 41800660
  2. ORPHA:567
    Orphanet
  3. GARD:10299
    GARD (NIH)
  4. Q525642
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Síndrome de deleção 22q11.2. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/sindrome-de-delecao-22q112

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de deleção 22q11.2
Compêndio · Raras BR

Síndrome de deleção 22q11.2

ORPHA:567 · MONDO:0018923
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
D82.1 · Síndrome de Di George
CID-11
Ensaios
10 ativos
Medicamentos
7 registrados
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0012236
EuropePMC
Wikidata
Wikipedia
Papers 10a
Evidência
🥉 Relato de caso

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara